Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute
LAVAL, QC. and WELLESLEY, MA., September 4, 2018 – Ampersand Capital Partners, together with the management team of NEOMED-LABS and the NEOMED Institute, announced today that Ampersand has partnered with management in the acquisition of NEOMED-LABS from its not-for-profit founder and parent, the NEOMED Institute.
NEOMED-LABS i
Read complete news
The NEOMED Institute is proud to be a Gold Sponsor of the 8th BioConnect Symposium jointly organized with the International Biotechnology Symposium (IBS2018)
The NEOMED Institute is pleased to announce its partnership with the BioConnect symposium, which will take place on August 16, 2018, as part of the International Biotechnology Symposium and Exhibition (IBS2018), at the Palais des congrès de Montréal (Montreal Convention Centre).
Montreal (QC), June 28, 2018
Read complete news
Pfizer Canada Invests in the NEOMED Institute to Further Support Growth in Quebec’s Life Sciences Sector
BOSTON (MA), June 5, 2018 – Pfizer Canada is proud to announce a $1,200,000 contribution to the NEOMED Institute. Pfizer Canada’s support will help NEOMED in its mission to accelerate the transformation of scientific discoveries from Quebec and Canadian universities into innovative therapeutic treatments.
Over the next three
Read complete news
GSK and NEOMED call for proposals for innovative early stage human therapeutic projects in Quebec
GSK and NEOMED are calling on Quebec-based researchers to submit their innovative projects in early drug discovery for potential funding under the GSK and NEOMED $2 million Discovery Fund.
Montreal, QC, Canada May 31st, 2018 – Today, GlaxoSmithKline Inc. (GSK) and the NEOMED Institute (NEOMED) are inviting
Read complete news
